Complete Steroid Avoidance Is Effective and Safe in Children With Renal Transplants: A Multicenter Randomized Trial With Three-Year Follow-Up
Minnie Sarwal(Stanford University), Oscar Salvatierra(Stanford University), David Kershaw(University of Michigan), Anthony A. Portale(University of California, San Francisco), Maarten Naesens(KU Leuven), Bradley A. Warady(Children's Mercy Hospital), J. Liu(Pharmaceutical Product Development (India)), H. Jorge Baluarte(Children's Hospital of Philadelphia), Tara K. Sigdel(City College of San Francisco), Janie Waskerwitz(Stanford University), Mark R. Benfield(University of Alabama), Li Li(Unknown), V. Matti Vehaskari(Children's Hospital of New Orleans), W. Harmon(Harvard University Press), Robert Mathias(University of California, San Francisco), Ruth A. McDonald(Seattle Children's Hospital), Elaine S. Kamil(Cedars-Sinai Medical Center), Robert B. Ettenger(University of California, Los Angeles), Liwu Tang(Pharmaceutical Product Development (India)), Vikas R. Dharnidharka(Johnson University)
Cited by 153
Related Papers
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
|New England Journal of Medicine|2003|697